Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors
Background. Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgery is considered adequate for stage I tumors. However, women treated conservatively have a relatively...
Gespeichert in:
| Veröffentlicht in: | Gynecologic oncology 2001-04, Vol.81 (1), p.63-66 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 66 |
|---|---|
| container_issue | 1 |
| container_start_page | 63 |
| container_title | Gynecologic oncology |
| container_volume | 81 |
| creator | Zanetta, Gerardo Rota, Sonia Lissoni, Andrea Meni, Alessandro Brancatelli, Gaetano (Tano) Buda, Alessandro |
| description | Background. Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgery is considered adequate for stage I tumors. However, women treated conservatively have a relatively small but well-defined risk of recurrence and no study has specifically addressed the optimal follow-up technique.
Methods. From 1981 to 1997, 164 women underwent fertility-sparing surgery for stage I borderline ovarian tumor and were followed prospectively. After surgery all women underwent physical examination and ultrasound examination every 3 months for 2 years after first diagnosis and every 6 months thereafter. Measurement of serum CA 125 levels was planned every 6 months in patients with a serous tumor.
Results. With a median follow-up of 71, months 28 women treated with fertility-sparing surgery (28/164 = 17%) had either recurrence of borderline tumor (23) or recurrence with carcinoma. Complete details of follow-up procedures are available for 24 women and they represent the study population. An abnormal adnexal mass was detected in 18 of 19 women with recurrent borderline tumor. One patient had diagnosis due to persistent free fluid. All five women with invasive carcinoma had diagnosis of a complex adnexal mass. Gynecologic examination was suspicious (palpable mass) in 7 cases and obviously abnormal (large mass or nodules) in another 7. CA 125 serum levels were elevated in 8 cases.
Conclusion. Transvaginal ultrasound is currently the most effective diagnostic technique for the follow-up of young patients treated conservatively for early borderline ovarian tumor. |
| doi_str_mv | 10.1006/gyno.2000.6099 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77009472</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090825800960992</els_id><sourcerecordid>77009472</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-65147d799486abe9a58da6726637726d6ff5c1be8f3485a3497f593df78bb3873</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhiMEotvClSOyhMSpWZwPx_axLFtAKiqC9mx57XFrlNjtOFmRX8LfxWFXcOLiuTzzavy8RfGqouuK0u7d3RziuqaUrjsq5ZNiVVHJyk4w-bRYUSppKWomTorTlH5kqqFV_bw4qaqa845Vq-LXbT-iTnEK9px8vZ-TN7on25968EGPPoZzooMlmwtS1Yx8AZ0mhAHCSFxEMt4D-QAjmIUk0ZFvYCZECAaIdiMg2cSQAPc5ag_k-4R3gPOf1a3GfibvI1rA3gcg13uNXgdyMw0R04vimdN9gpfHeVbcXm5vNp_Kq-uPnzcXV6Vpm3Ys8x9abrmUrej0DqRmwuqO113X8Pzazjlmqh0I17SC6aaV3DHZWMfFbtcI3pwVbw-5DxgfJ0ijGnwy0Pc6QJyS4jxLbHmdwfUBNBhTQnDqAf2gcVYVVUsVaqlCLVWopYq88PqYPO0GsP_wo_sMvDkCOmXpDnUwPv3lJBO0W2LEgYJsYe8BVTJ-EWw9Zu_KRv-_C34DCK-mGg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77009472</pqid></control><display><type>article</type><title>Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Zanetta, Gerardo ; Rota, Sonia ; Lissoni, Andrea ; Meni, Alessandro ; Brancatelli, Gaetano (Tano) ; Buda, Alessandro</creator><creatorcontrib>Zanetta, Gerardo ; Rota, Sonia ; Lissoni, Andrea ; Meni, Alessandro ; Brancatelli, Gaetano (Tano) ; Buda, Alessandro</creatorcontrib><description>Background. Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgery is considered adequate for stage I tumors. However, women treated conservatively have a relatively small but well-defined risk of recurrence and no study has specifically addressed the optimal follow-up technique.
Methods. From 1981 to 1997, 164 women underwent fertility-sparing surgery for stage I borderline ovarian tumor and were followed prospectively. After surgery all women underwent physical examination and ultrasound examination every 3 months for 2 years after first diagnosis and every 6 months thereafter. Measurement of serum CA 125 levels was planned every 6 months in patients with a serous tumor.
Results. With a median follow-up of 71, months 28 women treated with fertility-sparing surgery (28/164 = 17%) had either recurrence of borderline tumor (23) or recurrence with carcinoma. Complete details of follow-up procedures are available for 24 women and they represent the study population. An abnormal adnexal mass was detected in 18 of 19 women with recurrent borderline tumor. One patient had diagnosis due to persistent free fluid. All five women with invasive carcinoma had diagnosis of a complex adnexal mass. Gynecologic examination was suspicious (palpable mass) in 7 cases and obviously abnormal (large mass or nodules) in another 7. CA 125 serum levels were elevated in 8 cases.
Conclusion. Transvaginal ultrasound is currently the most effective diagnostic technique for the follow-up of young patients treated conservatively for early borderline ovarian tumor.</description><identifier>ISSN: 0090-8258</identifier><identifier>EISSN: 1095-6859</identifier><identifier>DOI: 10.1006/gyno.2000.6099</identifier><identifier>PMID: 11277651</identifier><identifier>CODEN: GYNOA3</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adenocarcinoma, Mucinous - diagnosis ; Adenocarcinoma, Mucinous - diagnostic imaging ; Adenocarcinoma, Mucinous - immunology ; Adenocarcinoma, Mucinous - surgery ; Adolescent ; Adult ; Biological and medical sciences ; borderline tumor ; CA-125 Antigen - blood ; Child ; Cystadenocarcinoma, Serous - diagnosis ; Cystadenocarcinoma, Serous - diagnostic imaging ; Cystadenocarcinoma, Serous - immunology ; Cystadenocarcinoma, Serous - surgery ; Female ; fertility ; follow-up ; Follow-Up Studies ; Genital system. Mammary gland ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Neoplasm Recurrence, Local - diagnosis ; Neoplasm Recurrence, Local - diagnostic imaging ; Neoplasm Recurrence, Local - immunology ; Neoplasm Recurrence, Local - surgery ; ovarian cancer ; Ovarian Neoplasms - diagnosis ; Ovarian Neoplasms - diagnostic imaging ; Ovarian Neoplasms - immunology ; Ovarian Neoplasms - surgery ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Physical Examination ; prognosis ; Prospective Studies ; Salvage Therapy ; Ultrasonography ; ultrasound</subject><ispartof>Gynecologic oncology, 2001-04, Vol.81 (1), p.63-66</ispartof><rights>2001 Academic Press</rights><rights>2001 INIST-CNRS</rights><rights>Copyright 2001 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-65147d799486abe9a58da6726637726d6ff5c1be8f3485a3497f593df78bb3873</citedby><cites>FETCH-LOGICAL-c434t-65147d799486abe9a58da6726637726d6ff5c1be8f3485a3497f593df78bb3873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/gyno.2000.6099$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=958069$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11277651$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zanetta, Gerardo</creatorcontrib><creatorcontrib>Rota, Sonia</creatorcontrib><creatorcontrib>Lissoni, Andrea</creatorcontrib><creatorcontrib>Meni, Alessandro</creatorcontrib><creatorcontrib>Brancatelli, Gaetano (Tano)</creatorcontrib><creatorcontrib>Buda, Alessandro</creatorcontrib><title>Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors</title><title>Gynecologic oncology</title><addtitle>Gynecol Oncol</addtitle><description>Background. Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgery is considered adequate for stage I tumors. However, women treated conservatively have a relatively small but well-defined risk of recurrence and no study has specifically addressed the optimal follow-up technique.
Methods. From 1981 to 1997, 164 women underwent fertility-sparing surgery for stage I borderline ovarian tumor and were followed prospectively. After surgery all women underwent physical examination and ultrasound examination every 3 months for 2 years after first diagnosis and every 6 months thereafter. Measurement of serum CA 125 levels was planned every 6 months in patients with a serous tumor.
Results. With a median follow-up of 71, months 28 women treated with fertility-sparing surgery (28/164 = 17%) had either recurrence of borderline tumor (23) or recurrence with carcinoma. Complete details of follow-up procedures are available for 24 women and they represent the study population. An abnormal adnexal mass was detected in 18 of 19 women with recurrent borderline tumor. One patient had diagnosis due to persistent free fluid. All five women with invasive carcinoma had diagnosis of a complex adnexal mass. Gynecologic examination was suspicious (palpable mass) in 7 cases and obviously abnormal (large mass or nodules) in another 7. CA 125 serum levels were elevated in 8 cases.
Conclusion. Transvaginal ultrasound is currently the most effective diagnostic technique for the follow-up of young patients treated conservatively for early borderline ovarian tumor.</description><subject>Adenocarcinoma, Mucinous - diagnosis</subject><subject>Adenocarcinoma, Mucinous - diagnostic imaging</subject><subject>Adenocarcinoma, Mucinous - immunology</subject><subject>Adenocarcinoma, Mucinous - surgery</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>borderline tumor</subject><subject>CA-125 Antigen - blood</subject><subject>Child</subject><subject>Cystadenocarcinoma, Serous - diagnosis</subject><subject>Cystadenocarcinoma, Serous - diagnostic imaging</subject><subject>Cystadenocarcinoma, Serous - immunology</subject><subject>Cystadenocarcinoma, Serous - surgery</subject><subject>Female</subject><subject>fertility</subject><subject>follow-up</subject><subject>Follow-Up Studies</subject><subject>Genital system. Mammary gland</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Neoplasm Recurrence, Local - diagnosis</subject><subject>Neoplasm Recurrence, Local - diagnostic imaging</subject><subject>Neoplasm Recurrence, Local - immunology</subject><subject>Neoplasm Recurrence, Local - surgery</subject><subject>ovarian cancer</subject><subject>Ovarian Neoplasms - diagnosis</subject><subject>Ovarian Neoplasms - diagnostic imaging</subject><subject>Ovarian Neoplasms - immunology</subject><subject>Ovarian Neoplasms - surgery</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Physical Examination</subject><subject>prognosis</subject><subject>Prospective Studies</subject><subject>Salvage Therapy</subject><subject>Ultrasonography</subject><subject>ultrasound</subject><issn>0090-8258</issn><issn>1095-6859</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1v1DAQhiMEotvClSOyhMSpWZwPx_axLFtAKiqC9mx57XFrlNjtOFmRX8LfxWFXcOLiuTzzavy8RfGqouuK0u7d3RziuqaUrjsq5ZNiVVHJyk4w-bRYUSppKWomTorTlH5kqqFV_bw4qaqa845Vq-LXbT-iTnEK9px8vZ-TN7on25968EGPPoZzooMlmwtS1Yx8AZ0mhAHCSFxEMt4D-QAjmIUk0ZFvYCZECAaIdiMg2cSQAPc5ag_k-4R3gPOf1a3GfibvI1rA3gcg13uNXgdyMw0R04vimdN9gpfHeVbcXm5vNp_Kq-uPnzcXV6Vpm3Ys8x9abrmUrej0DqRmwuqO113X8Pzazjlmqh0I17SC6aaV3DHZWMfFbtcI3pwVbw-5DxgfJ0ijGnwy0Pc6QJyS4jxLbHmdwfUBNBhTQnDqAf2gcVYVVUsVaqlCLVWopYq88PqYPO0GsP_wo_sMvDkCOmXpDnUwPv3lJBO0W2LEgYJsYe8BVTJ-EWw9Zu_KRv-_C34DCK-mGg</recordid><startdate>20010401</startdate><enddate>20010401</enddate><creator>Zanetta, Gerardo</creator><creator>Rota, Sonia</creator><creator>Lissoni, Andrea</creator><creator>Meni, Alessandro</creator><creator>Brancatelli, Gaetano (Tano)</creator><creator>Buda, Alessandro</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010401</creationdate><title>Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors</title><author>Zanetta, Gerardo ; Rota, Sonia ; Lissoni, Andrea ; Meni, Alessandro ; Brancatelli, Gaetano (Tano) ; Buda, Alessandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-65147d799486abe9a58da6726637726d6ff5c1be8f3485a3497f593df78bb3873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenocarcinoma, Mucinous - diagnosis</topic><topic>Adenocarcinoma, Mucinous - diagnostic imaging</topic><topic>Adenocarcinoma, Mucinous - immunology</topic><topic>Adenocarcinoma, Mucinous - surgery</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>borderline tumor</topic><topic>CA-125 Antigen - blood</topic><topic>Child</topic><topic>Cystadenocarcinoma, Serous - diagnosis</topic><topic>Cystadenocarcinoma, Serous - diagnostic imaging</topic><topic>Cystadenocarcinoma, Serous - immunology</topic><topic>Cystadenocarcinoma, Serous - surgery</topic><topic>Female</topic><topic>fertility</topic><topic>follow-up</topic><topic>Follow-Up Studies</topic><topic>Genital system. Mammary gland</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Neoplasm Recurrence, Local - diagnosis</topic><topic>Neoplasm Recurrence, Local - diagnostic imaging</topic><topic>Neoplasm Recurrence, Local - immunology</topic><topic>Neoplasm Recurrence, Local - surgery</topic><topic>ovarian cancer</topic><topic>Ovarian Neoplasms - diagnosis</topic><topic>Ovarian Neoplasms - diagnostic imaging</topic><topic>Ovarian Neoplasms - immunology</topic><topic>Ovarian Neoplasms - surgery</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Physical Examination</topic><topic>prognosis</topic><topic>Prospective Studies</topic><topic>Salvage Therapy</topic><topic>Ultrasonography</topic><topic>ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zanetta, Gerardo</creatorcontrib><creatorcontrib>Rota, Sonia</creatorcontrib><creatorcontrib>Lissoni, Andrea</creatorcontrib><creatorcontrib>Meni, Alessandro</creatorcontrib><creatorcontrib>Brancatelli, Gaetano (Tano)</creatorcontrib><creatorcontrib>Buda, Alessandro</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gynecologic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zanetta, Gerardo</au><au>Rota, Sonia</au><au>Lissoni, Andrea</au><au>Meni, Alessandro</au><au>Brancatelli, Gaetano (Tano)</au><au>Buda, Alessandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors</atitle><jtitle>Gynecologic oncology</jtitle><addtitle>Gynecol Oncol</addtitle><date>2001-04-01</date><risdate>2001</risdate><volume>81</volume><issue>1</issue><spage>63</spage><epage>66</epage><pages>63-66</pages><issn>0090-8258</issn><eissn>1095-6859</eissn><coden>GYNOA3</coden><abstract>Background. Borderline ovarian tumors often affect women of childbearing age and the prognosis is outstanding. Given the young age of several patients and the good prognosis, fertility-sparing surgery is considered adequate for stage I tumors. However, women treated conservatively have a relatively small but well-defined risk of recurrence and no study has specifically addressed the optimal follow-up technique.
Methods. From 1981 to 1997, 164 women underwent fertility-sparing surgery for stage I borderline ovarian tumor and were followed prospectively. After surgery all women underwent physical examination and ultrasound examination every 3 months for 2 years after first diagnosis and every 6 months thereafter. Measurement of serum CA 125 levels was planned every 6 months in patients with a serous tumor.
Results. With a median follow-up of 71, months 28 women treated with fertility-sparing surgery (28/164 = 17%) had either recurrence of borderline tumor (23) or recurrence with carcinoma. Complete details of follow-up procedures are available for 24 women and they represent the study population. An abnormal adnexal mass was detected in 18 of 19 women with recurrent borderline tumor. One patient had diagnosis due to persistent free fluid. All five women with invasive carcinoma had diagnosis of a complex adnexal mass. Gynecologic examination was suspicious (palpable mass) in 7 cases and obviously abnormal (large mass or nodules) in another 7. CA 125 serum levels were elevated in 8 cases.
Conclusion. Transvaginal ultrasound is currently the most effective diagnostic technique for the follow-up of young patients treated conservatively for early borderline ovarian tumor.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11277651</pmid><doi>10.1006/gyno.2000.6099</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0090-8258 |
| ispartof | Gynecologic oncology, 2001-04, Vol.81 (1), p.63-66 |
| issn | 0090-8258 1095-6859 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_77009472 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Adenocarcinoma, Mucinous - diagnosis Adenocarcinoma, Mucinous - diagnostic imaging Adenocarcinoma, Mucinous - immunology Adenocarcinoma, Mucinous - surgery Adolescent Adult Biological and medical sciences borderline tumor CA-125 Antigen - blood Child Cystadenocarcinoma, Serous - diagnosis Cystadenocarcinoma, Serous - diagnostic imaging Cystadenocarcinoma, Serous - immunology Cystadenocarcinoma, Serous - surgery Female fertility follow-up Follow-Up Studies Genital system. Mammary gland Humans Investigative techniques, diagnostic techniques (general aspects) Medical sciences Neoplasm Recurrence, Local - diagnosis Neoplasm Recurrence, Local - diagnostic imaging Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - surgery ovarian cancer Ovarian Neoplasms - diagnosis Ovarian Neoplasms - diagnostic imaging Ovarian Neoplasms - immunology Ovarian Neoplasms - surgery Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Physical Examination prognosis Prospective Studies Salvage Therapy Ultrasonography ultrasound |
| title | Ultrasound, Physical Examination, and CA 125 Measurement for the Detection of Recurrence after Conservative Surgery for Early Borderline Ovarian Tumors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T05%3A15%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ultrasound,%20Physical%20Examination,%20and%20CA%20125%20Measurement%20for%20the%20Detection%20of%20Recurrence%20after%20Conservative%20Surgery%20for%20Early%20Borderline%20Ovarian%20Tumors&rft.jtitle=Gynecologic%20oncology&rft.au=Zanetta,%20Gerardo&rft.date=2001-04-01&rft.volume=81&rft.issue=1&rft.spage=63&rft.epage=66&rft.pages=63-66&rft.issn=0090-8258&rft.eissn=1095-6859&rft.coden=GYNOA3&rft_id=info:doi/10.1006/gyno.2000.6099&rft_dat=%3Cproquest_cross%3E77009472%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77009472&rft_id=info:pmid/11277651&rft_els_id=S0090825800960992&rfr_iscdi=true |